Eloralintide And Tirzepatide
A Study of Eloralintide (LY3841136) and Eloralintide With Tirzepatide in Participants With Overweight or Obesity
Eli Lilly · Phase 1 · Completed · Enrollment 188
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Eloralintide and Tirzepatide-Cohorts A-D | n/r | n/r | n/r | n/r |
| Eloralintide-Cohorts E and F | n/r | n/r | n/r | n/r |
Not shown
- Eloralintide and Tirzepatide-Cohorts A-D: endpoint not reported
- Eloralintide-Cohorts E and F: endpoint not reported